Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3524336013 | Product containing daclizumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3714244013 | Daclizumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclizumab-containing product | Has active ingredient | Daclizumab | true | Inferred relationship | Some | 1 | |
| Daclizumab-containing product | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Some | ||
| Daclizumab-containing product | Is a | Monoclonal antibody-containing product | true | Inferred relationship | Some | ||
| Daclizumab-containing product | Is a | Murine-human monoclonal immunoglobulin G antibody product | false | Inferred relationship | Some | ||
| Daclizumab-containing product | Is a | Immunomodulator-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daclizumab only product | Is a | True | Daclizumab-containing product | Inferred relationship | Some | |
| Daclizumab-containing product in parenteral dose form | Is a | True | Daclizumab-containing product | Inferred relationship | Some | |
| Daclizumab 25mg/5mL infusion concentrate | Is a | False | Daclizumab-containing product | Inferred relationship | Some | |
| Daclizumab 25mg/5 mL solution | Is a | False | Daclizumab-containing product | Inferred relationship | Some | |
| Daclizumab 25mg/5mL infusion concentrate | Is a | False | Daclizumab-containing product | Inferred relationship | Some | |
| Daclizumab 25mg/5mL conventional release solution for injection | Is a | False | Daclizumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR